Fundamental analysis · SEC EDGAR · TTM through 31/03/2026

Fundamental analysis of Hca Healthcare, Inc.

HCA · NYSE · Services-General Medical & Surgical Hospitals, NEC

Fundamental quality

REASONABLE

60

out of 100

Breakdown by area

I.GrowthEPS: 13.7% · Revenue: 7.6%
62
II.ProfitabilityNet margin: 8.9% · ROE: -107.8%
43
III.Financial healthFCF: 10.4%
75

Source: SEC EDGAR · TTM through 31/03/2026

Reading the numbers

On average over recent years, earnings per share grew 13.7% a year and revenue advanced 7.6% a year.

On profitability, Hca Healthcare, Inc. shows a net margin of 8.9%, an ROE of -107.8%.

Its financial health shows a free cash flow margin of 10.4%.

Adding up growth, profitability and financial strength, the traffic light gives HCA a fundamental quality of 60 out of 100. To also know whether it's cheap or expensive, the price is missing: enter it in the tool and you'll get the valuation verdict (P/E against its sector).

The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.

Is Hca Healthcare, Inc. cheap or expensive?

That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).

Compute the valuation →
Advertising

Where to buy Hca Healthcare, Inc.?

Brokers you can use to invest in U.S. and European stocks.

Compare the brokers →